The World Health Organization (WHO) is raising a critical alarm about the shortage of new antibiotics fueling the rise of drug-resistant bacteria.
Since their discovery in the 1920s, antibiotics have revolutionized modern medicine, saving countless lives from bacterial infections. Yet bacteria have adapted through constant exposure, developing resistance that renders these vital treatments ineffective.
This leaves infections unchecked and deadly. Projections warn that antimicrobial resistance (AMR) could claim up to 10 million lives annually by 2050 without intervention.
The crisis is escalating. In April, England's former Chief Medical Officer, Professor Sally Davies, equated antibiotic resistance to a threat as grave as climate change.
She highlighted insufficient action: “There is no appetite [among pharmaceutical companies] to develop new drugs. There is a systemic failure.” Public health priorities often clash with profit motives.
WHO's recent reports underscore the urgency. Director-General Dr. Tedros Adhanom Ghebreyesus stated: “Never has the threat of antimicrobial resistance been more immediate and the need for solutions more urgent.” He urged countries and pharma industries to boost funding and innovation: “Many initiatives are underway to reduce resistance, but we also need... sustainable funding and innovative new medicines.”
Currently, about 50 antibiotics are in development, but none outperform existing options. Only two target the most critical resistant bacteria, per WHO data. Promising candidates in pre-clinical stages won't reach markets for at least a decade.
Beyond new drugs, we must drastically reduce antibiotic use. Agriculture and aquaculture are major culprits, consuming the vast majority globally for livestock.
A April UN Inter-Agency Coordination Group (IACG) report demanded a full ban on antibiotics as growth promoters in farming.
Related articles:
